Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.460
0.00 (0.00%)
Sep 4, 2025, 4:00 PM - Market closed
Humacyte Market Cap
Humacyte has a market cap or net worth of $231.22 million as of September 4, 2025. Its market cap has decreased by -69.39% in one year.
Market Cap
231.22M
Enterprise Value
277.16M
1-Year Change
-69.39%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $231.22M, an increase of 86.01%. That is a compound annual growth rate of 13.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 231.22M | -64.41% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
| Dec 1, 2020 | 124.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.38B |
| Johnson & Johnson | 428.68B |
| AbbVie | 374.26B |
| UnitedHealth Group | 278.84B |
| AstraZeneca | 254.65B |
| Novo Nordisk | 253.55B |
| Novartis AG | 248.54B |
| Abbott Laboratories | 230.05B |